Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) shares fell 3.7% during trading on Thursday . The company traded as low as $11.19 and last traded at $11.55. 134,670 shares traded hands during mid-day trading, a decline of 14% from the average session volume of 156,938 shares. The stock had previously closed at $12.00. Analysts […]
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) shares fell 3.7% during trading on Thursday . The company traded as low as $11.19 and last traded at $11.55. 134,670 shares traded hands during mid-day trading, a decline of 14% from the average session volume of 156,938 shares. The stock had previously closed at $12.00. Analysts […]
Mineralys Therapeutics (NASDAQ:MLYS) Rating Reiterated by Lifesci Capital themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report)‘s stock had its “outperform” rating reissued by research analysts at Lifesci Capital in a research note issued on Tuesday, Zacks.com reports. Lifesci Capital also issued estimates for Mineralys Therapeutics’ FY2024 earnings at ($2.04) EPS. Mineralys Therapeutics Trading Down 0.5 % NASDAQ:MLYS opened at $12.78 on Tuesday. The stock […]
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) major shareholder Samsara Biocapital Gp, Llc purchased 555,555 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was bought at an average cost of $13.50 per share, with a total value of $7,499,992.50. Following the purchase, the insider now owns 5,074,916 shares […]